Neuroendocrinology, Pituitary and Behaviour

ea0020p544 | Neuroendocrinology, Pituitary and Behaviour

The effects of selective serotononin reuptake inhibitors on the thyroid axis in perimenopausal depression

ea0020p545 | Neuroendocrinology, Pituitary and Behaviour

Pre-treatment IGF-I concentrations predict radiographic osteoarthritis in acromegalic patients with long-term cured disease

ea0020p546 | Neuroendocrinology, Pituitary and Behaviour

The prevalence of diabetes mellitus in 9776 adult patients with childhood- and adult-onset growth hormone (GH) deficiency before GH replacement: a KIMS analysis

ea0020p547 | Neuroendocrinology, Pituitary and Behaviour

Effects of 3 years growth hormone (GH) replacement in adult-onset growth hormone deficiency (GHD) due to controlled Cushing's disease (CD)

ea0020p548 | Neuroendocrinology, Pituitary and Behaviour

The cost-effectiveness of growth hormone (GH) treatment (Genotropin^®) in adult patients with growth hormone deficiency (GHD)

ea0020p549 | Neuroendocrinology, Pituitary and Behaviour

High TSH levels in healthy pregnant women are related to a decrease in motor development of their children at 14 months of age

ea0020p550 | Neuroendocrinology, Pituitary and Behaviour

Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly

ea0020p551 | Neuroendocrinology, Pituitary and Behaviour

The low-dose ACTH stimulation test in the assessment of outcome of pituitary surgery for Cushing's disease

ea0020p552 | Neuroendocrinology, Pituitary and Behaviour

The D3 GH receptor polymorphism is associated with osteoarthritis, especially of the hip, in patients with long-term cured acromegaly

ea0020p553 | Neuroendocrinology, Pituitary and Behaviour

Ghrelin as new provocative test for the diagnosis of GH deficiency in adults

ea0020p554 | Neuroendocrinology, Pituitary and Behaviour

Screening for neuroendocrine dysfunction in patients after spontaneous subarachnoid hemorrhage

ea0020p555 | Neuroendocrinology, Pituitary and Behaviour

Characterisation of PARS, a novel putative pituitary regulator of hormone secretion

ea0020p556 | Neuroendocrinology, Pituitary and Behaviour

Combined treatment for acromegaly with long-acting somatostatin analogues and pegvisomant: long-term safety up to 4.5 years of follow-up in 86 patients

ea0020p557 | Neuroendocrinology, Pituitary and Behaviour

Impact of long-term growth hormone (GH) substitution on lipid metabolism and bone mineralisation (BMD) in pituitary insufficient patients with growth hormone deficiency (GHD)

ea0020p558 | Neuroendocrinology, Pituitary and Behaviour

Effect of intracerebroventricular infusion of bombesin in glucose dependent insulinotropic peptide on conscious dogs

ea0020p559 | Neuroendocrinology, Pituitary and Behaviour

Plurihormonal cells are more frequent in early embryofetal stages of the human pituitary

ea0020p560 | Neuroendocrinology, Pituitary and Behaviour

Ovariectomy causes hippocampal neuronal loss and cognitive dysfunction and restored by Ginkgo biloba extract EGb761 in rats

ea0020p561 | Neuroendocrinology, Pituitary and Behaviour

Glucose tolerance and somatostatin analogues treatment in acromegaly: a 12 month open, prospective study

ea0020p562 | Neuroendocrinology, Pituitary and Behaviour

Heart rate variability of young men with hypogonadotropic hypogonadism

ea0020p563 | Neuroendocrinology, Pituitary and Behaviour

The impact of infertility on the relationship of people with a Pituitary condition

ea0020p564 | Neuroendocrinology, Pituitary and Behaviour

Carotid intima media thickness and other cardiovascular risk factors in acromegalic patients

ea0020p565 | Neuroendocrinology, Pituitary and Behaviour

Expression and regulation of HIF-1α and RSUME in murine and human pituitary tumor cells

ea0020p566 | Neuroendocrinology, Pituitary and Behaviour

MicroRNA expression in human sporadic pituitary adenomas

ea0020p567 | Neuroendocrinology, Pituitary and Behaviour

Progesterone up-regulates transthyretin levels in primary cultures of choroid plexus epithelial cells

ea0020p568 | Neuroendocrinology, Pituitary and Behaviour

Long-term follow-up of female patients with prolactinoma: is there a place for surgery in the therapy of prolactinoma?

ea0020p569 | Neuroendocrinology, Pituitary and Behaviour

Clinical presentation, long-term follow-up and bone morbidity of male patients with prolactinoma

ea0020p570 | Neuroendocrinology, Pituitary and Behaviour

Effects of somatostatin analogs on glucose homeostasis: a meta-analysis of acromegaly studies

ea0020p571 | Neuroendocrinology, Pituitary and Behaviour

Macroprolactinemia in patients with pituitary adenomas

ea0020p572 | Neuroendocrinology, Pituitary and Behaviour

Primary medical treatment of large and giant prolactinomas

ea0020p573 | Neuroendocrinology, Pituitary and Behaviour

Transport activities and plasma membrane localization of MCT8 mutant proteins identified in patients with severe psychomotor retardation depend on cell type. Implications for the interpretation of clinical phenotypes

ea0020p574 | Neuroendocrinology, Pituitary and Behaviour

Is it possible to avoid hypopituitarism after the irradiation of pituitary adenomas by the Leksell gamma-knife?

ea0020p575 | Neuroendocrinology, Pituitary and Behaviour

Effect of prolonged treatment with potassium canrenoate, a MR antagonist, on basal and stimulated hypothalamus–pituitary–adrenal (HPA) axis in humans

ea0020p576 | Neuroendocrinology, Pituitary and Behaviour

Initial and long-term outcome of surgery in acromegaly: a ten-year, single centre study in 115 patients

ea0020p577 | Neuroendocrinology, Pituitary and Behaviour

Two repeated restraint stress paradigms differing in duration and frequency result in similar levels of HPA habituation, but differences in neuropeptide expression and testosterone levels

ea0020p578 | Neuroendocrinology, Pituitary and Behaviour

Association of Interleukin-6 with hot flashes in perimenopausal women

ea0020p579 | Neuroendocrinology, Pituitary and Behaviour

Empty sella and primary autoimmune hypothyroidism

ea0020p580 | Neuroendocrinology, Pituitary and Behaviour

Human corticotropin releasing hormone (hCRH) test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis

ea0020p581 | Neuroendocrinology, Pituitary and Behaviour

Hemostatic and fibrinolytic changes in patients with Cushing's disease

ea0020p582 | Neuroendocrinology, Pituitary and Behaviour

Immunoassay determination of macroprolactin in hyperprolactinemic patients: an interassay comparative study

ea0020p583 | Neuroendocrinology, Pituitary and Behaviour

Adiponectin and visfatin: a link with bone mineral density in acromegaly

ea0020p584 | Neuroendocrinology, Pituitary and Behaviour

Feedback inhibition of prednisolone on vasopressin (AVP) secretion but preserved renal water reabsorption after thirsting point to an AVP independent antidiuretic action

ea0020p585 | Neuroendocrinology, Pituitary and Behaviour

Genetic alterations of phosphodiesterase 11A (PDE11A) in acromegalic patients

ea0020p586 | Neuroendocrinology, Pituitary and Behaviour

Neuroendocrine effects of stress in hostile heavy social drinkers: exploring the involvement of serotonin using dietary tryptophan manipulation

ea0020p587 | Neuroendocrinology, Pituitary and Behaviour

GH response to oral glucose tolerance test: a comparison between patients with pituitary disease and healthy subjects

ea0020p588 | Neuroendocrinology, Pituitary and Behaviour

Quality of life (QoL) in patients with Cushing's syndrome in a Spanish population: new experience with the CushingQoL questionnaire

ea0020p589 | Neuroendocrinology, Pituitary and Behaviour

Five year experience with GH replacement therapy on tumor occurrence or recurrence: one center study

ea0020p590 | Neuroendocrinology, Pituitary and Behaviour

Androgen deficiency is additional risk factor for bone health in growth hormone deficient men

ea0020p591 | Neuroendocrinology, Pituitary and Behaviour

The correlations of ghrelin concentrations and lipid profile in patients with acromegaly

ea0020p592 | Neuroendocrinology, Pituitary and Behaviour

Glucose metabolism alterations in acromegaly

ea0020p593 | Neuroendocrinology, Pituitary and Behaviour

ACTH-secreting bronchial carcinoid: a role of somatostatin analogues in diagnosis and treatment

ea0020p594 | Neuroendocrinology, Pituitary and Behaviour

Dose interval comparison of Lanreotide Autogel 120 mg in acromegalic patients previously treated with Octreotide LAR

ea0020p595 | Neuroendocrinology, Pituitary and Behaviour

Growth hormone replacement therapy in adult onset growth hormone deficiency induces favorable long-term effects on quality of life, bone, body composition and lipids: a 55 month prospective study

ea0020p596 | Neuroendocrinology, Pituitary and Behaviour

GH deficiency in HIV-infected patients with lipodystrophy: preliminary data on the effects of r-hGH treatment on body composition

ea0020p597 | Neuroendocrinology, Pituitary and Behaviour

Can the pineal gland modulate the effects of kisspeptin on the puberty onset in female rats?

ea0020p598 | Neuroendocrinology, Pituitary and Behaviour

Central diabetes insipidus after transsphenoidal treatment for tumors of the sellar region: prognostic factors for transient course of the disease

ea0020p599 | Neuroendocrinology, Pituitary and Behaviour

Food deprivation affects arcuate neurons in the hypothalamus of young rats

ea0020p600 | Neuroendocrinology, Pituitary and Behaviour

Plasma levels of neuropeptide Y and peptide YY in patients affected by Anorexia nervosa and severe obesity

ea0020p601 | Neuroendocrinology, Pituitary and Behaviour

From the horse’s mouth: recommendations to improve care for pituitary patients. Results from a survey on pituitary patients’ satisfaction with information and support from healthcare professionals

ea0020p602 | Neuroendocrinology, Pituitary and Behaviour

Pituitary insufficiency with a HESX1 mutation: a new case

ea0020p603 | Neuroendocrinology, Pituitary and Behaviour

Prevalence of colonic polyps in acromegalic patients and relationship between glycemic status

ea0020p604 | Neuroendocrinology, Pituitary and Behaviour

Results of acromegaly patients treated with surgery and/or somatostatin analog and/or radiotherapy in a University Hospital in Turkey

ea0020p605 | Neuroendocrinology, Pituitary and Behaviour

Hypothalamic–pituitary–adrenal axis in chronic fatigue syndrome

ea0020p606 | Neuroendocrinology, Pituitary and Behaviour

Normalization of ACTH and cortisol responses to ghrelin in patients cured from Cushing’s disease

ea0020p607 | Neuroendocrinology, Pituitary and Behaviour

The role of androgen receptors in the medial amygdala on biosynthesis and stress-induced cellular activation of the paraventricular nucleus of the hypothalamus

ea0020p608 | Neuroendocrinology, Pituitary and Behaviour

Health related quality of life in patients with diabetes mellitus type 2 in comparison to patients with other endocrine diseases

ea0020p612 | Neuroendocrinology, Pituitary and Behaviour

Pregnancy occurs rarely in acromegalic patients: although octreotide therapy in pregnancy seems to be feasible and safe, enough information regarding the use of OCT in pregnancy is not available yet

ea0020p613 | Neuroendocrinology, Pituitary and Behaviour

Observational outcome of Korean acromegalics based on OASIS registry

ea0020p614 | Neuroendocrinology, Pituitary and Behaviour

Plasma thrombin-activatable fibrinolysis inhibitor antigen levels in acromegalic patients

ea0020p615 | Neuroendocrinology, Pituitary and Behaviour

Prolactinoma in east-black sea Turkey: a description of 51 cases

ea0020p616 | Neuroendocrinology, Pituitary and Behaviour

Acromegaly in the eastern black sea region of Turkey: a description of 42 cases

ea0020p617 | Neuroendocrinology, Pituitary and Behaviour

11th European Congress of Endocrinology

BiosciAbstracts